au.\*:("MANZINO, L")
Results 1 to 25 of 26
Selection :
DIFFERENTIAL INHIBITORY EFFECTS OF ASCORBIC ACID ON THE BINDING OF DOPAMINE AGONISTS AND ANTAGONISTS TO NEOSTRIATAL MEMBRANE PREPARATIONS: CORRELATIONS WITH BEHAVIORAL EFFECTSHEIKKILA RE; CABBAT FS; MANZINO L et al.1981; RES. COMMUN. CHEM. PATHOL. PHARMACOL.; ISSN 0034-5164; USA; DA. 1981; VOL. 34; NO 3; PP. 409-421; BIBL. 14 REF.Article
INHIBITORY EFFECTS OF ASCORBIC ACID ON THE BINDING OF (3H) DOPAMINE ANTAGONISTS TO NEOSTRIATAL MEMBRANE PREPARATIONS: RELATIONSHIP TO LIPID PEROXIDATIONHEIKKILA RE; CABBAT FS; MANZINO L et al.1982; J. NEUROCHEM.; ISSN 0022-3042; GBR; DA. 1982; VOL. 38; NO 4; PP. 1000-1006; BIBL. 14 REF.Article
STEREOSPECIFIC BINDING OF 3H-DOPAMINE IN NEOSTRIATAL MEMBRANE PREPARATIONS: INHIBITORY EFFECTS OF SODIUM ASCORBATEHEIKKILA RE; CABBAT FJ; MANZINO L et al.1983; LIFE SCIENCES(1973); ISSN 0024-3205; GBR; DA. 1983; VOL. 32; NO 19; PP. 2183-2191; BIBL. 18 REF.Article
CIRCLING INDUCED BY DOPAMINE UPTAKE INHIBITORSDU VOISIN RC; HEIKKILA RE; MANZINO L et al.1978; J. PHARM. PHARMACOL.; GBR; DA. 1978; VOL. 30; NO 11; PP. 714-716; BIBL. 10 REF.Article
Behavioral properties of GBR 12909, GBR 13069 and GBR 13098: specific inhibitors of dopamine uptakeHEIKKILA, R. E; MANZINO, L.European journal of pharmacology. 1984, Vol 103, Num 3-4, pp 241-248, issn 0014-2999Article
POTENTIATION BY DEPRENIL OF L-DOPA INDUCED CIRCLING IN NIGRAL-LESIONED RATSHEIKKILA RE; CABBAT FS; MANZINO L et al.1981; PHARMACOL., BIOCHEM. BEHAV.; ISSN 0091-3057; USA; DA. 1981; VOL. 15; NO 1; PP. 75-79; BIBL. 17 REF.Article
UNEXPECTED DIFFERENCES BETWEEN MAZINDOL AND ITS HOMOLOGS ON BIOCHEMICAL AND BEHAVIORAL RESPONSESHEIKKILA RE; CABBAT FS; MANZINO L et al.1981; J. PHARMACOL. EXP. THER.; ISSN 0022-3565; USA; DA. 1981; VOL. 217; NO 3; PP. 745-749; BIBL. 20 REF.Article
ROTATIONAL BEHAVIOR INDUCED BY COCAINE ANALOGS IN RATS WITH UNILATERAL 6-HYDROXYDOPAMINE LESIONS OF THE SUBSTANTIA NIGRA: DEPENDENCE UPON DOPAMINE UPTAKE INHIBITIONHEIKKILA RE; CABBAT FS; MANZINO L et al.1979; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1979; VOL. 211; NO 1; PP. 189-194; BIBL. 14 REF.Article
Studies on the stability of 3H-dopamine, 3Hapomorphine and 3H-ADTN: effects of sodium ascorbate and EDTACABBAT, F. S; MANZINO, L; HEIKKILA, R. E et al.Research communications in chemical pathology and pharmacology. 1985, Vol 47, Num 3, pp 333-343, issn 0034-5164Article
Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrotriatal pathwaySONSALLA, P. K; MANZINO, L; HEIKKILA, R. E et al.The Journal of pharmacology and experimental therapeutics. 1988, Vol 247, Num 1, pp 180-185, issn 0022-3565Article
Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures : Relevance to parkinson's diseaseZEEVALK, G. D; MANZINO, L; SONSALLA, P. K et al.Experimental neurology (Print). 2007, Vol 203, Num 2, pp 512-520, issn 0014-4886, 9 p.Article
Isolated jejunal pouches for levodopa delivery in Parkinsonian patients with «on»off». Successful experimental model in dogsSAGE, J. I; TROOSKIN, S; SCHUH, L et al.Clinical neuropharmacology. 1988, Vol 11, Num 3, pp 212-220, issn 0362-5664Article
Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine and related compounds on the uptake of [3H]3,4-dihydroxyphenylethylamine and [3H]5-hydroxytryptamine in neostriatal synaptosomal preparationsHEIKKILA, R. E; YOUNGSTER, S. K; MANZINO, L et al.Journal of neurochemistry. 1985, Vol 44, Num 1, pp 310-313, issn 0022-3042Article
Some features of the nigrostriatal dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouseHEIKKILA, R. E; SIEBER, B.-A; MANZINO, L et al.Neurochemical pathology. 1989, Vol 10, Num 3, pp 171-183, issn 0734-600X, 13 p.Article
1-Methyl-4-phenylpyridine (MPP+): regional dopamine neuron uptake, toxicity, and novel rotational behavior following dopamine receptor proliferationALTAR, C. A; HEIKKILA, R. E; MANZINO, L et al.European journal of pharmacology. 1986, Vol 131, Num 2-3, pp 199-209, issn 0014-2999Article
Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and several of its analogues on the dopaminergic nigrostriatal pathway in miceHEIKKILA, R. E; MANZINO, L; CABBAT, F. S et al.Neuroscience letters. 1985, Vol 58, Num 1, pp 133-137, issn 0304-3940Article
Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in miceHEIKKILA, R. E; CABBAT, F. S; MANZINO, L et al.Neuropharmacology. 1984, Vol 23, Num 6, pp 711-713, issn 0028-3908Article
Rat model of Parkinson's disease : Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)YAZDANI, U; GERMAN, D. C; LIANG, C.-L et al.Experimental neurology (Print). 2006, Vol 200, Num 1, pp 172-183, issn 0014-4886, 12 p.Article
In vivo vulnerability of dopamine neurons to inhibition of energy metabolismZEEVALK, G. D; MANZINO, L; HOPPE, J et al.European journal of pharmacology. 1997, Vol 320, Num 2-3, pp 111-119, issn 0014-2999Article
Meige syndrome in the spectrum of Lewy body diseaseMARK, M. H; SAGE, J. I; DICKSON, D. W et al.Neurology. 1994, Vol 44, Num 8, pp 1432-1436, issn 0028-3878Article
Studies on the oxidation of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine by monoamine oxidase BHEIKKILA, R. E; MANZINO, L; CABBAT, F. S et al.Journal of neurochemistry. 1985, Vol 45, Num 4, pp 1049-1054, issn 0022-3042Article
WAY-318068: a novel, potent and selective noradrenaline re-uptake inhibitor with activity in rodent models of pain and depressionWHITESIDE, G. T; DWYER, J. M; LU, P et al.British journal of pharmacology. 2010, Vol 160, Num 5, pp 1105-1118, issn 0007-1188, 14 p.Article
MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in ratsSONSALLA, P. K; ZEEVALK, G. D; MANZINO, L et al.Journal of neurochemistry. 1992, Vol 58, Num 5, pp 1979-1982, issn 0022-3042Article
